Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 12026-08-24NCT05546580

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Oryzon Genomics S.A.3

13 results · Page 1 of 1

Swipe the table sideways for more columns.